B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6634-6641

  Chen, Liangen ^a   Zhang, Zheng ^a   Chen, Weiwei ^a   Zhang, Zhidong ^b   Li, Yonggang ^a   Shi, Ming ^a   Zhang, Jiyuan ^a   Chen, Lieping ^b,c   Wang, Shengdian ^b   Wang, Fu Sheng ^a  

^a BEIJING 302 HOSPITAL   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ADAPTIVE IMMUNITY; ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DENDRITIC CELL; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; VIRUS RESISTANCE;

EID: 34248185086     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6634     Document Type: Article

References (44)

1. Guidotti, L. G., and F. V. Chisari. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. Mech. Dis. 1: 23-61.
2. Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5: 215-229.
3. Webster, G. J., S. Reignat, M. K. Maini, S. A. Whalley, G. S. Ogg, A. King, D. Brown, P. L. Amlot, R. Williams, D. Vergani, et al. 2000. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32: 1117-1124.
4. + cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191: 1269-1280.
5. Kakimi, K., M. Isogawa, J. Chung, A. Sette, and F. V. Chisari. 2002. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J. Virol. 76: 8609-8620.
6. Stoop, J. N., R. G. van der Molen, C. C. Baan, L. J. van der Laan, E. J. Kuipers, J. G. Kusters, and H. L. Janssen. 2005. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41: 771-778.
7. + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177: 739-747.
8. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
9. Liu, Y. J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106: 259-262.
10. Akbar, S. M., S. Furukawa, A. Hasebe, N. Horiike, K. Michitaka, and M. Onji. 2004. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrier. Int. J. Mol. Med. 14: 295-299.
11. Lu, W., L. C. Arraes, W. T. Ferreira, and J. M. Andrieu. 2004. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10: 1359-1365.
12. Chen, M., Y. G. Li, D. Z. Zhang, Z. Y. Wang, W. Q. Zeng, X. F. Shi, Y. Guo, S. H. Guo, and H. Ren. 2005. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study. World J. Gastroenterol. 11: 1806-1808.
13. Pachiadakis, T., G. Pollara, B. M. Chain, and N. V. Naoumov. 2005. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect. Dis. 5: 296-304.
14. Zhang, Z., J. Fu, Q. Zhao, Y. He, L. Jin, H. Zhang, J. Yao, L. Zhang, and F. S. Wang. 2006. Differential restoration of myeloid and plasmacytoid dendritic cells in HIV-1-infected children after treatment with highly active antiretroviral therapy. J. Immunol. 176: 5644-5651.
15. Ulsenheimer, A., J. T. Gerlach, M. C. Jung, N. Gruener, M. Wachtler, M. Backmund, T. Santantonio, W. Schraut, M. H. Heeg, C. A. Schirren, et al. 2005. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 41: 643-651.
16. Wertheimer, A. M., A. Bake, and H. R. Rosen. 2004. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40: 335-345.
17. Duan, X. Z., M. Wang, H. W. Li, H. Zhuang, D. Xu, and F. S. Wang. 2004. Decreased frequency and function of circulating plasmacytoid dendritic cells (pDC) in hepatitis B virus infected humans. J. Clin. Immunol. 24: 637-646.
18. Van der Molen, R. G., D. Sprengers, R. S. Binda, E. C. de Jong, H. G. Niesters, J. G. Kusters, J. Kwekkeboom, and H. L. Janssen. 2004. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40: 738-746.
19. Zheng, B. J., J. Zhou, D. Qu, K. L. Siu, T. W. Lam, H. Y. Lo, S. S. Lee, and Y. M. Wen. 2004. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J. Viral Hepat. 11: 217-224.
20. Chen, L. 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4: 336-347.
21. Nishimura, H., and T. Honjo. 2000. PD-1 an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22: 265-268.
22. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
23. Martin-Orozco, N., Y. H. Wang, H. Yagita, and C. Dong. 2006. Cutting edge: programmed death (PD) ligand-1/PD-1 interaction is required for CD8 T cell tolerance to tissue antigens. J. Immunol. 177: 8291-8295.
24. + T cell activation. Eur. J. Immunol. 36: 2472-2482.
25. Brown, J. A., D. M. Dorfman, F. R. Ma, E. L. Sullivan, O. Munoz, C. R. Wood, E. A. Greenfield, and G. J. Freeman. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170: 1257-1266.
26. Dong, H., and L. Chen. 2003. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 81: 281-287.
27. Curiel, T. J., S. Wei, H. Dong, X. Alvarez, P. Cheng, P. Mottram, R. Krzysiek, K. L. Knutson, B. Daniel, M. C. Zimmermann, et al. 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 19: 562-567.
28. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203: 2223-2227.
29. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 669-670.
30. Traballoni, D., M. Saresella, M. Biasin, A. Boasso, L. Piacentini, P. Ferrante, H. Dong, R. Maserati, G. M. Shearer, L. Chen, et al. 2003. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 101: 2514-2520.
31. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
32. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
33. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
34. + T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J. Virol. 80: 3532-3540.
35. + monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels. J. Viral Hepat. 13: 725-733.
36. Urbani, S., B. Amadei, D. Tola, M. Massari, S. Schivazzappa, G. Missale, and C. Ferrari. 2006. PD-1 expression in acute hepatitis C is associated with HCV-specific CD8 exhaustion. J. Virol. 80: 11398-11403.
37. Zhang, Z., D. Chen, J. Yao, H. Zhang, L. Jin, M. Shi, H. Zhang, and F. S. Wang. 2007. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and serum aminotransferase in immune active pediatric patients with chronic hepatitis B. Clin. Immunol. 122: 173-180.
38. Lehner, M., P. Morhart, A. Stilper, and W. Holten 2005. Functional characterization of monocyte-derived dendritic cells generated under serum free culture conditions. Immunol. Lett. 99: 209-216.
39. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
40. Muhlbauer, M., M. Fleck, C. Schutz, T. Weiss, M. Froh, C. Blank, J. Scholmerich, and C. Hellerbrand. 2006. PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis. J. Hepatol. 45: 520-528.
41. Mazanet, M. M., and C. C. Hughes. 2002. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169; 3581-3588.
42. Sprengers, D., R. G. van der Molen, J. G. Kusters, B. Hansen, H. G. Niesters, S. W. Schalm, and H. L. Janssen. 2006. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B. J. Med. Virol. 78: 561-568.
43. Untergasser, A., U. Zedler, A. Langenkamp, M. Hosel, M. Quasdorff, K. Esser, H. P. Dienes, B. Tappertzhofen, W. Kolanus, and U. Protzer. 2006. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 43: 539-547.
44. Akbar, S. M., N. Horiike, and M. Onji. 2006. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World J. Gastroenterol. 12: 2876-2883.